Measuring risk in end-stage renal disease: Is N-terminal pro brain natriuretic peptide a useful marker?

Kidney International

Volumn 71, Issue 6, 2007, Pages 481-483

  Rosner, M H ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

AGING; CONGESTIVE HEART FAILURE; CORRELATION ANALYSIS; DIAGNOSTIC TEST; DISEASE SEVERITY; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HORMONE ACTION; HUMAN; KIDNEY FAILURE; MEDICAL INFORMATION; MORTALITY; PRIORITY JOURNAL; REVIEW;

EID: 33947096556     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002140     Document Type: Note

References (14)

1. Zoccali C. Traditional and emerging cardiovascular and renal risk factors: an epidemiologic perspective. Kidney Int 2006; 70: 26-33.
2. Nakao K, Itoh H, Suga S et al. The natriuretic peptide family. Curr Opin Nephrol Hypertens 1993; 2: 45-50.
3. Levin E, Garner D, Sampson K. Natriuretic peptides. N Engl J Med 1998; 339: 321-328.
4. Yamamota K, Burnett J, Jougasaki M et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 1996; 28: 988-994.
5. Maisel A. B-type natriuretic peptide levels: a potential novel "white count" for congestive heart failure. J Card Fail 2001; 7: 183-193.
6. McCullough PA, Sandberg KR. B-type natriuretic peptide and renal disease. Heart Fail Rev 2003; 8: 355-358.
7. Wahl HG, Graf S, Renz H, Fassbinder W. Elimination of the cardiac natriuretic peptides B-type natriuretic peptide (BNP) and N-terminal proBNP by hemodialysis. Clin Chem 2004; 50: 1071-1074.
8. Madsen LH, Ladefoged S, Corell P et al. N-terminal pro brain natriuretic peptide predicts mortality in patients with end-stage renal disease in hemodialysis. Kidney Int 2007; 71: 548-554.
9. Joffy S, Rosner MH. Natriuretic peptides in ESRD. Am J Kidney Dis 2005; 46: 1-10.
10. Cataliotti A, Maltino L, Jougasaki M et al. Circulating natriuretic peptide concentrations in patients with end stage renal disease: role of brain natriuretic peptide as a biomarker of ventricular remodeling. Mayo Clin Proc 2001; 76: 1111-1119.
11. Naganuma T, Sugimura K, Wada S et al. The prognostic role of brain natriuretic peptides in hemodialysis patients. Am J Nephrol 2002; 22: 437-444.
12. Zoccali C, Mallamaci F, Benedetto F et al. Cardiac natriuretic peptides are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol 2001; 12: 1508-1515.
13. Apple FS, Murakami MM, Pearce LA, Herzog CA. Multi-biomarker risk stratification of N-terminal-B-type natriuretic peptide, high-sensitivity Creactive protein, and cardiac troponin T and I in end-stage renal disease for all-cause death. Clin Chem 2004; 50: 2279-2285.
14. Morrow DA, de Lemos JA, Blazing MA et al. Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease. JAMA 2005; 294: 2866-2871.